openPR Logo
Press release

Necrotising Enterocolitis Market Worldwide Healthy Growth Rate with Topmost Players Abbott Laboratories Inc, Bayer HealthCare AG, Enzon Pharmaceuticals, Medtronic Plc and More – Outlook Till 2023

01-10-2019 08:13 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Necrotising Enterocolitis Market

Necrotising Enterocolitis Market

Market Scenario for Necrotising Enterocolitis Market:

The Global Necrotising Enterocolitis (NEC) Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the Necrotising Enterocolitis (NEC) market is expected to register a CAGR 5.5% during the forecast period of 2018 to 2023.

Necrotizing enterocolitis is the most common cause of gastrointestinal-related morbidity and mortality. The most premature infants are the most vulnerable. According to a study published in the Advances in Neonatal Care (2013), it was estimated that approximately 12% of infants born with the body weight of less than 1500 g are likely to develop Necrotizing Enterocolitis. The ascites condition is also found to be associated with Stage IIa and IIIa. The severity of the condition pushes the demand for better diagnosis and treatment approaches.

Request Sample Report at https://www.marketresearchfuture.com/sample_request/5999

Various other factors such as improved reimbursement policies in developed countries, improving regulatory framework, growing research funding, unmet medical needs, and increasing government assistance are continuously contributing to the growth of the global Necrotising Enterocolitis (NEC) market. The increasing contribution of marketers is also fueling the growth of the market. For instance, on February 15, 2018, Prometic Life Sciences Inc. received the FDA orphan drug designation status to its Inter-Alpha-Inhibitor-Proteins ("IaIp") for the treatment of necrotizing enterocolitis.

Despite these drivers, there are some issues associated with the Necrotising Enterocolitis (NEC) market. The complications associated with the treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.

Key Players for Necrotising Enterocolitis Market:

Some of the key players in the global necrotising enterocolitis (NEC) market are Abbott Laboratories Inc. (U.S.), Astellas Pharma Inc. (Japan), Bayer HealthCare AG (Germany), Becton, Dickinson and Company (BD) (U.S.), Bristol-Myers Squibb Company (U.S.), Daiichi Sankyo Company , Ltd. (Japan), Eli Lilly and Co. (U.S.), Enzon Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), GI Supply (U.S.), GlaxoSmithKline Plc (UK), Kyorin Pharmaceutical Co., Ltd. (U.S.), Medtronic Plc (U.S.), Merck & Co. Inc. (U.S.), MiddleBrook Pharmaceuticals (Japan), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Sanofi-Aventis (France), Sequana Medical AG (Switzerland), Takeda Pharmaceutical Company, Ltd. (Japan), and others.

Segmentation for Necrotising Enterocolitis Market:  

The global Necrotising Enterocolitis (NEC) market is segmented on the basis of stage, diagnosis, treatment, and end-user.

Based on stage, the market is classified as Stage I, Stage II, and Stage III. The Stage II is further segmented into Stage IIa and Stage IIb. The Stage III is further segmented into Stage IIIa and Stage IIIb.

Based on diagnosis, the market is classified as imaging, laboratory studies, and differential diagnosis. The imaging segment is further classified as abdominal x-ray, Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, angiography, and others. The laboratory studies segment is further classified as haemochromocytometric exam, blood culture, serum electrolytes, arterial blood gas analysis, blood pressure monitor, and others. The differential diagnosis segment is further classified as ileus secondary to neonatal sepsis, spontaneous intestinal perforation, ileal atresia, intestinal malrotation, volvulus, neonatal appendicitis, neonatal pseudomembranous colitis, and others.

Based on treatment, the market is classified as Total Parenteral Nutrition (TPN), gastrointestinal decompression, antimicrobial therapy, antifungal treatment, paracentesis, and others.

Based on end-user, the market is classified as hospitals and clinics, ambulatory surgical center, diagnostic centers, and others.

Regional Analysis for Necrotising Enterocolitis Market:

The global Necrotising Enterocolitis (NEC) market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global Necrotising Enterocolitis (NEC) market owing to the use of numerous therapies for the treatment of Necrotising Enterocolitis (NEC) along with the demand for early diagnosis. For instance, in 2013, Necrotising Enterocolitis (NEC) was the cause of 355 deaths per 100,000 live births in the United States. The death toll was virtually three times higher in the black population than for the white population.

Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/necrotising-enterocolitis-market-5999

The European region is the second largest market for global Necrotising Enterocolitis (NEC) due to the surging demand for antifungal drugs. Moreover, factors favoring the growth of Necrotising Enterocolitis (NEC) in the Asia Pacific region are the implementation of various healthcare reforms such as Patient Protection and Affordable Care Act (PPACA), increasing investments in the Asia Pacific region offering huge market potential, and rapidly increasing aging population.

The Middle East and Africa is projected to show steady growth in this market due to a subsequent rise in the number of neonatal diseases along with the growing healthcare infrastructure in remote areas.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Necrotising Enterocolitis Market Worldwide Healthy Growth Rate with Topmost Players Abbott Laboratories Inc, Bayer HealthCare AG, Enzon Pharmaceuticals, Medtronic Plc and More – Outlook Till 2023 here

News-ID: 1485741 • Views: 101

More Releases from Market Research Future

Clinical Trial Management System Market Demand, Industry Share, Size, Applicatio …
Clinical Trial Management System Market Analysis by Type (Enterprise Clinical Trial Management System), Delivery Model (Licensed Enterprise), Component (Service) and End-User (Medical Device Manufacturers), and Regional Competitive Share, Size and Trends, 2018-2023 Market Overview Clinical Trial Management System Market is mostly a software system which helps to plan, prepare, and manage a large amount of clinical trials data that is produced by biotechnological and pharmaceutical companies. Drug research has gained momentum in
Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to
Commercial Airport Lighting Market 2019-2023 | Worldwide Overview By Technology, …
Global Commercial Airport Lighting Market Research Report: Information by Technology (LED, Non-LED), by Application (Airside Lighting, Terminal Lighting, Landside Lighting), and by Region — Forecast till 2023 Honeywell International Inc., (US), ADB SAFEGATE (US), ABB (Switzerland), vosla GmBH (Germany), Avlite (Australia), Carmanah (Canada), Eaton (Ireland), atg airports limited (UK), Avionics Group (US), and HELLA GmBH & Co. KGaA (Germany) are some of the prominent players profiled in MRFR Analysis and are

All 5 Releases


More Releases for Enterocolitis

Necrotising Enterocolitis Market Worldwide Healthy Growth Rate with Topmost Play …
Market Research Future has Published Prime Research Report on the Global Necrotising Enterocolitis (NEC) Market. Segmented on the Basis of Stage, Diagnosis, Treatment, and End-User. Market Scenario for Necrotising Enterocolitis Market: The Global Necrotising Enterocolitis (NEC) Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the Necrotising Enterocolitis (NEC) market is expected to register a CAGR 5.5% during the forecast period of 2018 to 2023. Necrotizing enterocolitis
Necrotising Enterocolitis Market Worldwide Healthy Growth Rate with Topmost Play …
Market Research Future has Published Prime Research Report on the Global Necrotising Enterocolitis (NEC) Market. Segmented on the Basis of Stage, Diagnosis, Treatment, and End-User. Market Scenario for Necrotising Enterocolitis Market: The Global Necrotising Enterocolitis (NEC) Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the Necrotising Enterocolitis (NEC) market is expected to register a CAGR 5.5% during the forecast period of 2018 to 2023. Necrotizing enterocolitis
Necrotising Enterocolitis Market Application, Opportunity And Forecast To 2023 …
Market Scenario The global Necrotising Enterocolitis (NEC) market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the Necrotising Enterocolitis (NEC) market is expected to register a CAGR 5.5% during the forecast period of 2018 to 2023. Necrotizing enterocolitis is the most common cause of gastrointestinal-related morbidity and mortality. The most premature infants are the most vulnerable. According to a study published in the Advances in Neonatal Care (2013),
Enterocolitis Market Demand, Overview, Price and Forecasts To 2022
ReportBazzar has released its latest research-based report entitled ‘Enterocolitis’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Enterocolitis market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Enterocolitis market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact
Enterocolitis Market Pit Falls, Present Scenario and Growth Prospects from 2017 …
ReportBazzar has released its latest research-based report entitled ‘Enterocolitis’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Enterocolitis market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Enterocolitis market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact
Enterocolitis - Pipeline Review, H1 2017 - Pharmaceuticals Market Report
Enterocolitis is an inflammation of the large and small intestines. Symptoms include fever, abdominal swelling, nausea, diarrhea, rectal bleeding and sluggishness. Causes of enterocolitis include Inflammation of the intestinal tissues, delayed gastric emptying, abdominal wall erythema, apnea, sepsis and cardiovascular collapse. Treatment includes antibiotics. Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068452 Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Enterocolitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics